Cutler Group LP Infinity Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 25, 2022	SELL	$0.59 - $1.7 $59 - $170	-100 Reduced 33.33%	200 $0
Q4 2021 Jan 18, 2022	SELL	$1.86 - $3.36 $17,670 - $31,920	-9,500 Reduced 96.94%	300 $0
Q3 2021 Oct 26, 2021	BUY	$1.52 - $3.82 $14,136 - $35,526	9,300 Added 1860.0%	9,800 $1,000
Q4 2017 Jan 17, 2018	BUY	$1.22 - $3.73 $610 - $1,865	500	500 $0

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.